Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: Results from the TRACER trial
- Claes Held
- , Pierluigi Tricoci
- , Zhen Huang
- , Frans Van de Werf
- , Harvey D. White
- , Paul W. Armstrong
- , Giuseppe Ambrosio
- , Philip E. Aylward
- , David J. Moliterno
- , Lars Wallentin
- , Edmond Chen
- , Aycan Erkan
- , Lixin Jiang
- , John Strony
- , Robert A. Harrington
- , Kenneth w. Mahaffey
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations